Advertisement

Neuroscience Bulletin

, Volume 31, Issue 5, pp 541–549 | Cite as

Automated rapid iterative negative geotaxis assay and its use in a genetic screen for modifiers of Aβ42-induced locomotor decline in Drosophila

  • Haiyan Liu
  • Meng Han
  • Qingyi Li
  • Xiao Zhang
  • Wen-An WangEmail author
  • Fu-De HuangEmail author
Original Article

Abstract

The negative-geotaxis climbing assay is used to efficiently study aging and neurodegeneration in Drosophila. To make it suitable for large-scale study, a method called the rapid iterative negative geotaxis (RING) assay has been established by simultaneously photographing the climbing of multiple groups of flies when they are manually tapped down in test tubes. Here, we automated the assay by using a well-controlled electric motor to drive the tapping, and a homemade program to analyze the climbing height of flies. Using the automated RING (aRING) assay, we found that the climbing ability of a strain of wild-type flies, males in particular, declined rapidly before day 21 after eclosion, but slowly from day 21 to 35. We also found that the expression of arctic mutant Aβ42 accelerated the age-dependent decline in the climbing ability of flies. Moreover, using aRING, we examined the effect of third chromosome deficiencies on the accelerated locomotor decline in Aβ42-expressing flies, and isolated 7 suppressors and 15 enhancers.

Keywords

RING negative geotaxis giant fiber age-dependent locomotor decline Drosophila beta amyloid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Supplementary material

12264_2014_1526_MOESM1_ESM.docx (10 kb)
Supplementary material, approximately 10.2 KB.

Supplementary material, approximately 3.98 MB.

Supplementary material, approximately 4.23 MB.

References

  1. [1]
    Bilen J, Bonini NM. Drosophila as a model for human neurodegenerative disease. Annu Rev Genet 2005, 39: 153–171.CrossRefPubMedGoogle Scholar
  2. [2]
    Marsh JL, Thompson LM. Drosophila in the study of neurodegenerative disease. Neuron 2006, 52: 169–178.CrossRefPubMedGoogle Scholar
  3. [3]
    Pandey UB, Nichols CD. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 2011, 63: 411–436.PubMedCentralCrossRefPubMedGoogle Scholar
  4. [4]
    Jones MA, Grotewiel M. Drosophila as a model for age-related impairment in locomotor and other behaviors. Exp Gerontol 2011, 46: 320–325.PubMedCentralCrossRefPubMedGoogle Scholar
  5. [5]
    Feany MB, Bender WW. A Drosophila model of Parkinson’s disease. Nature 2000, 404: 394–398.CrossRefPubMedGoogle Scholar
  6. [6]
    Gargano JW, Martin I, Bhandari P, Grotewiel MS. Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila. Exp Gerontol 2005, 40: 386–395.CrossRefPubMedGoogle Scholar
  7. [7]
    Podratz JL, Staff NP, Boesche JB, Giorno NJ, Hainy ME, Herring SA, et al. An automated climbing apparatus to measure chemotherapy-induced neurotoxicity in Drosophila melanogaster. Fly (Austin) 2013, 7: 187–192.CrossRefGoogle Scholar
  8. [8]
    Zhao XL, Wang WA, Tan JX, Huang JK, Zhang X, Zhang BZ, et al. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. J Neurosci 2010, 30: 1512–1522.CrossRefPubMedGoogle Scholar
  9. [9]
    Rhodenizer D, Martin I, Bhandari P, Pletcher SD, Grotewiel M. Genetic and environmental factors impact age-related impairment of negative geotaxis in Drosophila by altering age-dependent climbing speed. Exp Gerontol 2008, 43: 739–748.PubMedCentralCrossRefPubMedGoogle Scholar
  10. [10]
    Lin JY, Wang WA, Zhang X, Liu HY, Zhao XL, Huang FD. Intraneuronal accumulation of Abeta42 induces age-dependent slowing of neuronal transmission in Drosophila. Neurosci Bull 2014, 30: 185–190.CrossRefPubMedGoogle Scholar
  11. [11]
    Huang JK, Ma PL, Ji SY, Zhao XL, Tan JX, Sun XJ, et al. Age-dependent alterations in the presynaptic active zone in a Drosophila model of Alzheimer’s Disease. Neurobiol Dis 2013, 51: 161–167.CrossRefPubMedGoogle Scholar
  12. [12]
    Mossmann D, Vogtle FN, Taskin AA, Teixeira PF, Ring J, Burkhart JM, et al. Amyloid-beta peptide induces mitochondrial dysfunction by inhibition of preprotein maturation. Cell Metab 2014, 20: 662–669.CrossRefPubMedGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of NeurologyXin Hua Hospital Affiliated to Shanghai Jiaotong University School of MedicineShanghaiChina
  2. 2.Center for Stem Cell and NanoMedicine, Laboratory for System Biology, Shanghai Advanced Research InstituteChinese Academy of SciencesShanghaiChina
  3. 3.Institute of Neuroscience and State Key Laboratory of Neuroscience, Shanghai Institutes for Biological SciencesChinese Academy of SciencesShanghaiChina
  4. 4.Department of NeurologyXin Hua Hospital Chongming Branch Affiliated to Shanghai Jiaotong University School of MedicineShanghaiChina

Personalised recommendations